brain neoplasm: A neoplasm (disease) that involves the brain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
500 |
4. Check minimum number of eventsNone |
500 |
5. Include endpointsNone |
500 |
6. Filter based on genotype QC (FinnGen only) |
500 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum medullae spinalis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Spinal cord
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Spinal cord
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2876 | 1502 | 1358 |
| Only index persons | 2586 | 1356 | 1230 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 52.72 | 54.48 | 50.76 |
| Only index persons | 52.31 | 53.93 | 50.53 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 500 | 271 | 229 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.10 |
| Median age at first event (years) | 54.11 | 53.44 | 54.90 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 450
- Matched controls
- 4500
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
+∞
286.0
243
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
3082.1
202.0
180
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
81.8
76
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
25.2
78.8
113
59
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
+∞
74.0
69
*
D33.43
ICD-10 Finland
Spinal cord
+∞
72.9
68
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
70.7
66
*
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
+∞
70.7
66
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
86.0
54.5
60
8
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
299.6
53.4
53
*
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
+∞
49.9
47
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
18.1
35.7
56
35
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
375.0
35.5
35
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
34.8
33
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.3
31.3
138
424
N03AX16
ATC
pregabalin; oral
3.7
30.9
171
638
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
30.6
29
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
5.6
29.3
92
196
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
30.0
27.1
36
13
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
27.8
26.6
36
14
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
29.0
26.2
35
13
N03AX12
ATC
gabapentin; oral
3.9
25.9
123
396
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
91.8
23.9
26
*
D33.42
ICD-10 Finland
Hemangioblastoma of the spinal cord
+∞
23.1
22
*
N02AX02
ATC
tramadol; systemic, rectal
2.8
23.1
235
1278
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
20.9
75
182
9394/1-C72.0
ICD-O-3
Myxopapillary ependymoma of spinal cord
+∞
19.9
19
*
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
30.5
19.9
26
9
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
19.8
169
803
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
9.6
19.6
40
45
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.8
19.1
56
108
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
187.1
17.6
18
*
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
16.8
16
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.2
16.7
53
112
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
15.7
15
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
15.7
15
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
15.7
96
363
L28
ICPC
Limited function/disability (L)
3.1
14.9
92
348
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
58.7
14.9
17
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
154.8
14.5
15
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
7.3
14.2
34
50
M03BX01
ATC
baclofen; systemic
9.8
13.7
27
29
22530
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
13.6
13
*
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
144.2
13.5
14
*
ZXC40
NOMESCO Finland
Use of ultrasound
41.4
13.2
16
*
M54.5
ICD-10 Finland
Low back pain
2.2
12.7
165
932
D33.30
ICD-10 Finland
Acoustic neuroma
33.1
12.6
16
5
N02BE01
ATC
paracetamol; systemic, rectal
2.7
12.6
397
3307
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.5
12.5
60
188
SPAT1153
SPAT
Removal of sutures
2.1
11.9
169
986
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.5
11.9
57
179
WX402
NOMESCO Finland
General anaesthesia
2.5
11.6
97
438
2253A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
11.5
11
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
123.0
11.5
12
*
AA1AD
NOMESCO Finland
CT of head and brain
2.3
11.4
127
662
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
11.6
11.1
20
18
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.0
10.9
66
244
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
10.8
57
193
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
61.5
10.7
12
*
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
10.5
10
*
9161/1-C72.0
ICD-O-3
Hemangioblastoma of spinal cord
+∞
10.5
10
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
33.4
10.4
13
*
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
5.7
10.3
29
54
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.8
10.0
42
118
R4110
NOMESCO Finland
Physiotherapy
2.1
9.7
139
798
M48.0
ICD-10 Finland
Spinal stenosis
2.8
9.7
67
269
WX110
NOMESCO Finland
Local anesthesy
1.9
9.7
316
2466
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
9.4
9
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
9.4
9
*
D33.14
ICD-10 Finland
Hemangioblastoma and cerebellum
+∞
9.4
9
*
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
+∞
9.4
9
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.5
9.3
79
358
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
9.1
63
254
Z31.5
ICD-10 Finland
Genetic counselling
3.7
9.0
38
108
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
9.0
110
590
G82.2
ICD-10 Finland
Paraplegia, unspecified
24.6
8.9
12
5
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.8
8.8
28
61
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
14.4
8.7
14
10
N06AX21
ATC
duloxetine; oral
2.7
8.7
61
247
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
8.6
84
408
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
91.7
8.4
9
*
2312
FHL
Extirpation or destruction
+∞
8.4
8
*
N18
ICPC
Paralysis/weakness
7.8
8.2
18
24
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.4
8.1
38
118
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
8.1
138
842
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
7.8
170
1128
S18
ICPC
Laceration/cut
1.8
7.7
197
1371
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
18.7
7.6
11
6
XKD00
NOMESCO Finland
Uroflowmetry
2.2
7.5
81
411
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
81.4
7.4
8
*
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
11.1
7.3
13
12
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
+∞
7.3
7
*
N75
ICPC
Benign neoplasm nervous system
+∞
7.3
7
*
UKC02
NOMESCO Finland
Cystoscopy
2.2
7.2
77
389
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
7.2
56
243
R4120
NOMESCO Finland
Occupational therapy
3.1
7.1
38
131
M03BX02
ATC
tizanidine; oral
1.7
7.1
275
2150
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
7.1
57
250
N06AA09
ATC
amitriptyline; systemic
2.5
6.9
53
226
R33
ICD-10 Finland
Retention of urine
2.8
6.8
41
153
N02AA05
ATC
oxycodone; systemic
2.2
6.8
68
333
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
40.7
6.8
8
*
TAB00
NOMESCO Finland
Lumbar puncture
3.5
6.7
30
91
N28
ICPC
Limited function/disability (N)
8.0
6.7
14
18
L03
ICPC
Low back symptom/complaint
1.9
6.6
110
658
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
6.6
168
1156
A02BC02
ATC
pantoprazole; systemic
1.7
6.6
271
2136
A06AD11
ATC
lactulose; oral
2.2
6.5
66
324
M54.2
ICD-10 Finland
Cervicalgia
2.8
6.5
41
156
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
6.5
177
1242
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
70.8
6.4
7
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
6.3
190
1365
9421/1-C72.0
ICD-O-3
Pilocytic astrocytoma of spinal cord
+∞
6.3
6
*
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
6.3
6
*
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
27.1
6.2
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
47
27
19.11
58.24
1.6
1.8
—
—
—
0
0
(4035726)
107
355
3.56
26.97
1.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
120
447
3.22
24.98
8.6
10.3
mmol/l
1.5
1.3
0.36
94
361
(3033658) Prothrombin time (PT) actual/Normal
204
1047
2.60
23.01
3.7
3.8
%
91.2
91.4
0.03
197
1026
(3044640) Blood type and Crossmatch panel - Blood
234
1307
2.49
21.76
2.2
2.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
289
1807
2.42
20.51
7.1
6.3
mmol/l
1.2
1.2
0.42
274
1628
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
305
1970
2.41
19.87
8.2
7.2
mmol/l
1.2
1.2
0.47
274
1668
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
294
1934
2.26
17.44
4.2
4.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
182
992
2.31
16.94
2.2
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
341
2405
2.31
16.81
6.4
5.1
mmol/l
6.4
6.7
1.90
323
2249
(40768804) Tissue Pathology biopsy report
259
1667
2.15
15.62
2.5
2.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
46
5.19
11.10
3.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
19
8.11
11.06
1.9
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
31
80
4.07
11.00
1.8
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
220
1467
1.89
10.76
3.9
3.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
238
1635
1.87
10.54
7.8
8.5
inr
1.2
1.2
0.03
45
489
(3016018) Differential panel - Cerebral spinal fluid
19
35
5.60
10.00
1.8
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
183
1172
1.89
9.97
3.6
3.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
187
1221
1.85
9.49
2.4
2.1
u/l
215.1
194.2
0.17
180
1158
(3031040) Bacteria [#/volume] in Urine by Automated count
340
2667
1.86
9.34
6.4
4.3
e6/l
968.4
1758.3
—
5
46
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
122
696
2.00
9.29
2.8
2.6
e6/l
0.7
1.1
1.59
72
398
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
42
4.92
9.14
2.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
20
42
4.92
9.14
2.9
1.2
nmol/l
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
241
1716
1.78
9.06
5.3
4.7
g/l
35.7
35.9
0.19
227
1613
(3000850) Epithelial cells [#/volume] in Urine
140
844
1.91
9.04
2.8
2.5
e6/l
2.9
5.9
2.40
124
737
(3011397) Hemoglobin [Presence] in Urine by Test strip
149
917
1.89
9.03
4.2
3.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
173
1118
1.84
8.98
3.6
3.0
e6/l
0.4
0.4
0.11
144
833
(3002582) Erythrocytes [#/volume] in Urine
183
1234
1.76
8.07
3.8
3.1
e6/l
17.8
98.1
0.89
147
950
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
5
22.44
8.04
1.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
166
1094
1.77
7.89
3.8
3.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
111
650
1.91
7.70
3.0
2.8
e6/l
1.7
2.4
0.50
62
356
(3018095) Leukocytes [#/volume] in Urine
206
1454
1.71
7.61
4.5
3.5
e6/l
30.1
113.3
1.89
157
1027
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
92
514
1.97
7.31
6.5
6.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
344
2804
1.73
7.26
5.5
4.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
55
255
2.30
7.06
7.4
6.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
161
1088
1.71
6.83
4.7
4.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
37
4.43
6.53
2.1
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
103
619
1.84
6.52
1.7
2.0
s
30.2
29.6
0.25
103
603
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
461
4167
2.36
6.49
19.0
13.6
mg/l
21.6
23.1
0.52
384
3264
(3026782) Osmolality of Urine
124
791
1.75
6.42
2.8
2.7
mosm/kgh2o
519.4
554.4
1.07
108
670
(3001604) Monocytes [#/volume] in Blood
264
2052
1.61
6.31
5.9
5.9
e9/l
0.6
0.6
0.45
219
1783
(3013707) Erythrocyte sedimentation rate by Westergren method
365
3084
1.68
6.11
4.5
4.0
mm/h
10.0
11.4
1.31
343
2833
(3012095) Magnesium [Moles/volume] in Serum or Plasma
105
649
1.78
6.03
3.7
3.5
mmol/l
0.8
0.8
0.10
100
614
(3013650) Neutrophils [#/volume] in Blood by Automated count
300
2421
1.60
6.00
9.3
9.4
e9/l
4.1
4.1
0.03
263
2121
(3000991) Gas panel - Venous blood
60
308
2.08
5.99
11.5
10.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
263
2061
1.58
5.94
6.0
5.9
e9/l
0.0
0.0
0.05
217
1796
(3013115) Eosinophils [#/volume] in Blood
271
2139
1.58
5.93
6.2
6.3
e9/l
0.2
0.2
0.04
230
1893
(3044889) 12 lead EKG panel
346
2902
1.62
5.78
4.1
3.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
85
500
1.84
5.72
4.8
5.5
mmol/l
1.0
1.0
0.30
79
468
(3020891) Body temperature
37
158
2.45
5.72
7.8
4.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
169
1202
1.61
5.70
4.1
3.7
ph
7.4
7.4
0.34
28
227
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
218
1658
1.56
5.47
2.4
2.2
nmol/l
77.7
76.5
0.25
205
1475
(3029937) Albumin [Presence] in Urine by Test strip
154
1082
1.61
5.42
5.1
3.8
estimate
0.0
0.0
0.00
49
363
(3009261) Glucose [Presence] in Urine by Test strip
259
2051
1.55
5.39
4.8
3.5
estimate
0.0
0.0
0.50
46
356
(3019198) Lymphocytes [#/volume] in Blood
265
2113
1.54
5.32
6.0
5.9
e9/l
2.0
1.9
0.09
221
1879
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
372
3207
1.62
5.25
8.9
7.5
u/l
73.5
78.1
2.47
364
2997
(3035350) Ketones [Presence] in Urine by Test strip
254
2016
1.53
5.15
4.5
3.5
estimate
0.0
0.0
0.00
44
368
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
205
1556
1.54
5.10
3.6
3.5
ng/l
24.6
34.4
0.82
133
1071
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
365
3155
1.58
4.86
4.6
3.8
pmol/l
14.8
14.7
0.31
333
2849
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
42
209
2.10
4.57
15.2
14.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
90
574
1.69
4.56
1.4
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
250
2022
1.47
4.37
5.7
4.7
estimate
0.0
0.0
0.00
48
374
(4024509)
12
31
3.94
4.28
1.5
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
178
1358
1.48
4.12
4.0
3.4
mmol/l
2.4
2.4
0.62
161
1180
(42870588) Differential panel, method unspecified - Blood
178
1360
1.48
4.09
6.6
5.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
50
277
1.89
4.06
1.6
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
76
478
1.70
4.05
2.0
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
240
1945
1.45
4.05
6.6
6.3
%
8.7
8.6
0.16
226
1826
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
262
2165
1.44
3.95
7.7
6.3
umol/l
10.3
11.1
1.21
252
2051
(3022096) Basophils/100 leukocytes in Blood
232
1882
1.43
3.82
6.4
6.0
%
0.7
0.7
0.12
219
1760
(3006504) Eosinophils/100 leukocytes in Blood
237
1932
1.43
3.79
6.4
6.0
%
2.8
2.8
0.00
223
1802
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
102
709
1.55
3.62
1.4
1.3
iu/ml
21.7
37.7
1.57
29
218
(3003694) ABO and Rh group [Type] in Blood
150
1132
1.46
3.59
1.3
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
242
1994
1.41
3.58
6.5
6.0
%
28.3
27.9
0.21
228
1866
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
418
3820
1.57
3.49
5.5
4.5
mu/l
1.8
2.2
0.60
384
3486
(3023410) Appearance of Cerebral spinal fluid
13
42
3.15
3.39
1.8
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
104
738
1.52
3.35
3.3
2.8
mmol/l
2.4
2.4
0.09
90
653
(40761511) CBC panel - Blood by Automated count
464
4366
1.87
3.33
18.0
12.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
149
1144
1.43
3.21
3.0
3.1
ng/l
947.1
1049.1
0.18
120
974
(3018010) Neutrophils/100 leukocytes in Blood
237
1974
1.38
3.17
6.2
5.8
%
56.9
57.1
0.10
225
1856
(3019150) Specific gravity of Urine by Refractometry
121
897
1.46
3.13
5.8
3.7
kg/l
1.0
1.0
0.69
16
129
(3045414) Leukocytes [Presence] in Urine
32
167
1.98
3.12
2.0
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
48
286
1.75
3.12
3.0
2.7
ng/l
151.5
159.0
0.06
42
255
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
48
287
1.74
3.08
2.7
2.5
au/ml
23.3
14.3
—
6
12
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
107
2.20
3.01
1.6
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
128
970
1.43
2.94
2.3
2.0
mg/l
3.1
3.1
0.10
107
820
(40761535) Cells panel - Urine sediment
54
342
1.65
2.83
3.7
3.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
233
1.78
2.82
1.8
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
23
3.96
2.78
1.1
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
134
1036
1.40
2.73
6.9
7.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
120
1538
0.71
2.70
2.9
2.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
124
948
1.41
2.69
1.5
1.5
nmol/l
21.6
21.5
0.02
109
793
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
416
3855
1.47
2.66
5.7
5.7
mmol/mol
38.3
39.7
3.20
391
3583
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
25
3.65
2.58
1.3
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
109
2.07
2.50
1.9
2.5
u/ml
0.4
0.4
—
9
60
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
194
1611
1.33
2.48
2.1
1.9
pmol/l
93.3
96.3
0.42
105
835
(3019225) pH of Specimen
59
395
1.56
2.48
3.6
4.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
51
331
1.60
2.44
2.0
2.4
ml/min/173m2
96.1
68.3
0.44
19
142
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
170
1388
1.34
2.43
4.0
3.3
u/l
35.8
31.5
0.48
165
1328
(3006462) Nitrate [Presence] in Urine
7
17
4.16
2.36
10.1
3.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
25
133
1.93
2.35
1.4
1.4
mu/l
289.8
268.1
0.28
25
122
(3002032) Base excess in Venous blood by calculation
51
335
1.58
2.33
3.1
3.5
mmol/l
2.4
1.9
0.42
44
264
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
13
4.66
2.27
1.2
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
13
4.66
2.27
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
91
679
1.42
2.25
1.3
1.3
u/ml
3.3
11.7
2.14
41
265
(3048689) Calprotectin [Mass/mass] in Stool
70
498
1.47
2.23
1.7
2.2
ug/g
106.7
125.5
0.31
53
387
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
48
2.54
2.20
1.4
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
48
2.54
2.20
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
14
4.32
2.15
1.2
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
14
4.32
2.15
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
33
198
1.71
2.14
2.8
3.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
82
606
1.42
2.14
2.4
2.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
116
1.94
2.14
3.6
3.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
158
1300
1.31
2.10
3.5
2.5
u/l
51.8
57.2
1.54
147
1197
(3007164) IgA [Mass/volume] in Serum or Plasma
108
840
1.36
2.09
1.3
1.5
g/l
2.3
2.5
0.49
66
523
(4034850)
24
132
1.86
2.07
10.1
9.1
—
—
—
0
0
(4211845)
7
20
3.53
2.06
10.1
3.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
58
405
1.49
2.03
4.0
3.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
40
257
1.60
2.02
2.1
2.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
98
1.98
1.98
1.2
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
85
2.04
1.92
2.6
4.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
482
4672
1.88
1.91
28.0
20.0
e9/l
251.4
249.2
0.33
477
4559
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
186
1581
1.28
1.90
4.9
3.6
—
—
—
0
0
(3012544) pH of Venous blood
51
353
1.50
1.88
3.2
3.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
135
1104
1.31
1.85
4.8
4.3
%
20.1
20.9
0.26
74
491
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
130
1.81
1.85
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
207
1790
1.27
1.83
2.7
2.6
ug/l
102.2
124.5
1.62
192
1638
(36660697) Celiac disease serology panel - Serum
47
322
1.51
1.82
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
71
528
1.40
1.80
1.2
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
482
4679
1.84
1.79
28.1
20.0
g/l
135.4
136.6
1.19
482
4611
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
132
1.78
1.77
1.3
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
421
3982
1.36
1.75
16.1
12.4
ml/min/173m2
85.9
83.1
1.72
372
3269
(3049717) Cytology report of Urine Cyto stain
27
163
1.69
1.75
2.2
2.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
18
3.36
1.75
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
49
342
1.48
1.74
2.7
2.5
ug/l
4.8
6.7
0.52
44
304
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
243
1.56
1.73
2.7
3.7
mmol/l
2.3
1.8
0.29
24
185
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
116
939
1.31
1.71
1.3
1.2
u/ml
2.4
1.3
0.29
34
255
(42529406) Shigella sp [Presence] in Stool by Culture
23
134
1.75
1.69
1.3
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
14
3.60
1.62
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
84
1.93
1.61
2.1
2.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
297
2702
1.24
1.61
2.9
3.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
20
3.02
1.58
1.7
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
50
2.23
1.58
1.4
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
145
1.69
1.57
1.3
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
84
658
1.33
1.56
2.3
1.9
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
33
2.45
1.54
1.0
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
113
925
1.29
1.53
1.7
1.8
mg/l
1.1
1.2
0.16
84
702
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
15
3.36
1.52
1.8
2.1
%
103.8
115.9
—
5
15
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
44
0.00
1.52
0.0
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
309
2835
1.24
1.50
4.1
3.1
u/l
46.0
48.8
0.38
303
2658
(3026389) Candida sp identified in Specimen by Organism specific culture
9
37
2.46
1.48
1.1
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
209
1843
1.23
1.48
10.2
9.3
e9/l
0.0
0.0
0.73
156
1511
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
45
2.25
1.47
1.1
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
38
2.39
1.46
1.7
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
39
2.33
1.43
1.3
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
72
559
1.34
1.43
1.3
1.4
titre
496.0
512.0
0.03
15
120
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
74
1.92
1.40
2.4
2.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
126
1057
1.26
1.39
3.1
2.7
umol/l
344.2
7616.3
4.60
114
903
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
161
0.49
1.38
1.3
1.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
9
41
2.22
1.37
5.8
3.0
u/ml
26.8
54.6
—
9
41
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
426
4073
1.31
1.35
4.9
4.5
mmol/l
5.9
5.9
0.14
395
3725
(3037121) Protein [Mass/volume] in Urine
23
144
1.63
1.34
2.6
3.7
g/l
0.1
0.2
0.52
12
60
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
24
2.52
1.30
1.7
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
462
4476
1.42
1.29
12.6
10.2
u/l
26.1
26.9
0.50
451
4314
(3017704) Immunofixation for Urine
5
18
2.79
1.29
1.2
2.3
—
—
—
0
0
(4268621)
9
44
2.06
1.27
2.0
2.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
6
25
2.42
1.24
16.8
8.2
mmol/l
0.6
0.6
—
6
25
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
45
2.02
1.24
1.1
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
109
1.68
1.20
2.4
1.7
iu/l
4.5
6.5
—
7
34
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
133
1.60
1.19
1.1
2.4
g/l
2.8
3.1
0.70
14
108
(3023520) Reticulocytes [#/volume] in Blood
43
318
1.39
1.18
2.3
2.8
e9/l
67.3
73.3
0.64
32
243
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
11
57
1.95
1.18
1.0
1.2
u/ml
8.5
1.4
—
6
17
(3022621) pH of Urine by Test strip
37
268
1.41
1.14
3.9
2.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
59
462
1.31
1.13
1.4
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
51
1.98
1.12
1.8
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
35
253
1.41
1.10
1.1
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
66
1.84
1.10
1.2
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
21
2.39
1.09
3.8
3.3
umol/l
27.2
34.9
—
5
14
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
113
1.62
1.07
1.3
1.1
u/ml
4.8
13.6
—
5
14
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
39
289
1.38
1.07
1.3
1.2
iu/ml
83.7
124.8
0.41
14
116
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
156
1375
1.20
1.06
5.5
4.8
ug/l
2.2
2.2
0.08
140
1239
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
221
1.43
1.05
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
46
1.97
1.04
5.6
4.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
46
1.97
1.04
1.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
60
1.85
1.03
1.8
1.7
%
50.6
63.1
1.18
11
60
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
49
1.85
0.99
2.2
2.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
132
1.54
0.98
1.2
2.4
g/l
8.8
10.3
0.94
14
117
(4027681)
5
23
2.19
0.98
1.4
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
225
1.40
0.97
1.3
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
20
133
1.52
0.96
2.4
2.2
ug/l
592.7
277.5
0.35
20
122
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
66
538
1.26
0.95
2.3
2.2
%
21.2
22.7
0.45
58
468
(3007566) Smooth muscle Ab [Titer] in Serum
6
116
0.51
0.95
1.0
1.2
—
97.8
—
0
9
(3011648) Oxygen content in Venous blood
6
27
2.24
0.93
1.7
1.7
%
9.0
11.8
—
6
27
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
159
1.47
0.93
1.8
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
65
531
1.26
0.92
4.8
4.4
%
31.4
31.8
0.12
50
352
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
57
460
1.27
0.90
2.6
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
13
79
1.66
0.88
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
144
1.48
0.88
1.1
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
144
1.48
0.88
1.1
2.3
g/l
3.2
3.6
1.40
14
107
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
144
1.48
0.88
1.1
2.3
g/l
6.4
7.3
1.88
14
112
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
33
247
1.36
0.88
1.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
90
767
1.21
0.87
4.7
3.8
ng/l
337.6
262.0
0.14
74
579
(3022948) Iron [Moles/volume] in Serum or Plasma
75
628
1.23
0.86
2.4
2.2
umol/l
13.4
13.2
0.08
69
580
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
137
1.48
0.85
2.7
2.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
63
519
1.24
0.84
1.8
1.7
%
1.6
1.5
0.17
55
454
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
48
383
1.28
0.83
3.6
2.5
u/l
31.8
36.1
0.28
42
321
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
18
122
1.49
0.81
1.6
2.2
%
98.9
90.1
1.01
18
117
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
47
1.71
0.81
2.0
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
106
1.53
0.80
1.4
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
6
33
1.83
0.79
1.5
1.5
u/ml
0.6
0.4
—
6
16
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
25
0.00
0.79
0.0
2.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
48
1.68
0.79
1.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
82
1.60
0.78
8.9
2.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
123
1.48
0.78
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
30
226
1.35
0.78
1.1
1.2
—
—
—
0
0
(4010399)
38
297
1.30
0.78
1.7
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
35
271
1.31
0.77
6.8
2.8
e9/l
4.2
4.0
0.27
26
223
(3023419) Bacteria identified in Sputum by Culture
10
59
1.71
0.76
6.1
3.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
59
1.71
0.76
1.1
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
56
462
1.24
0.75
2.6
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
411
0.76
0.74
1.4
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
31
237
1.33
0.74
2.6
3.3
g/l
128.2
127.3
0.08
31
232
(4306422)
9
55
1.65
0.74
1.0
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
38
1.85
0.74
1.6
2.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
38
1.85
0.74
2.4
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
133
1192
1.16
0.73
3.0
3.2
mg/l
1260.5
164.5
0.89
91
770
(3013512) EKG study
134
1202
1.16
0.73
4.4
3.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
60
1.68
0.72
1.1
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
60
1.68
0.72
1.1
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
60
1.68
0.72
1.1
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
60
1.68
0.72
1.1
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
92
801
1.18
0.72
3.3
2.9
ug/l
0.6
0.7
0.82
66
502
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
76
1.59
0.72
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
204
1.34
0.70
3.7
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
363
3488
1.15
0.69
22.2
16.8
%
13.7
13.7
0.34
357
3426
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
433
4217
1.20
0.69
5.2
4.9
mmol/l
2.7
2.8
0.23
405
3878
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
144
1.41
0.69
1.9
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
61
1.65
0.69
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
69
1.61
0.69
1.8
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
69
1.61
0.69
1.8
1.4
—
—
—
0
0
(4062490)
7
42
1.68
0.68
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
42
1.68
0.68
2.3
2.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
67
572
1.20
0.66
2.2
2.2
g/l
2.3
2.4
0.29
62
528
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
62
1.63
0.65
1.0
1.1
u/ml
3.0
4.0
—
5
22
(40760892) CBC W Ordered Manual Differential panel - Blood
108
962
1.16
0.65
4.3
4.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
49
1.64
0.62
5.4
3.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
63
1.60
0.62
1.4
1.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.5
g/l
1.1
1.0
—
5
30
(3017181) Myelocytes/100 leukocytes in Blood
42
345
1.24
0.61
5.2
4.5
%
0.8
0.9
0.06
14
109
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
52
440
1.20
0.58
2.3
2.6
%
1.7
1.8
0.35
44
404
(3003327) Ova and parasites identified in Stool by Light microscopy
19
141
1.36
0.57
1.5
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
98
1.44
0.57
1.3
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
89
0.56
0.56
1.2
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
89
0.56
0.56
1.2
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
89
0.56
0.56
1.2
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
89
0.56
0.56
1.2
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
55
1.46
0.56
1.1
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
13
91
1.44
0.53
2.5
2.7
kpa
8.6
8.0
0.59
13
82
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
197
1.28
0.52
2.3
2.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
269
0.77
0.51
1.6
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
107
0.65
0.49
2.0
4.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
108
0.64
0.49
1.3
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
76
1.46
0.48
1.7
2.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
424
4150
1.14
0.47
4.7
4.4
mmol/l
4.6
4.7
0.20
400
3844
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
146
1.31
0.47
1.2
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
85
1.42
0.47
1.3
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
94
1.39
0.46
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
164
0.73
0.45
4.8
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
164
0.73
0.45
4.8
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
163
0.73
0.44
5.2
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
91
825
1.13
0.44
1.5
1.7
pmol/l
83951051.7
7321080.8
0.44
81
683
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
127
0.70
0.44
6.1
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
162
0.73
0.43
4.8
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
394
3847
1.11
0.43
20.9
14.7
%
39.4
40.4
1.09
282
2812
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
93
0.64
0.42
1.5
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
149
1.29
0.42
1.6
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(44806118)
8
58
1.39
0.41
2.6
1.6
—
—
—
0
0
(44790049)
8
58
1.39
0.41
2.6
1.6
—
—
—
0
0
(44790048)
8
58
1.39
0.41
2.6
1.6
—
—
—
0
0
(44790047)
8
58
1.39
0.41
2.6
1.6
—
—
—
0
0
(4094501)
14
105
1.34
0.41
1.2
1.1
—
—
—
0
0
(44806420)
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
8.7
—
0
18
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
61
1.32
0.39
1.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
78
709
1.12
0.37
1.7
1.7
nmol/l
1304.6
1238.6
0.13
61
535
(3001019) Free T4 and TSH panel - Serum or Plasma
25
207
1.22
0.37
1.9
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
35
301
1.18
0.36
5.2
4.8
%
0.0
1.2
—
10
80
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
77
0.65
0.36
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
78
0.64
0.36
1.4
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
43
1.40
0.35
1.3
1.2
—
—
—
0
0
(4146454)
6
45
1.34
0.34
2.7
2.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
248
1.18
0.32
3.7
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
47
1.28
0.32
1.3
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
98
0.71
0.31
2.6
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
54
1.30
0.30
1.3
3.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
84
1.32
0.30
1.0
1.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
12
93
1.30
0.30
1.3
1.7
e6/l
4255.1
10223.9
—
7
66
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
93
1.30
0.30
1.2
1.2
—
1.0
—
0
7
(3016879) Cocaine [Presence] in Urine
12
151
0.79
0.28
4.8
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
137
1299
1.08
0.28
3.3
3.0
mmol/l
7.7
7.7
0.02
119
1081
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
64
1.25
0.27
1.4
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
34
384
0.88
0.27
1.6
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
36
319
1.14
0.27
5.6
4.7
%
0.1
0.1
0.23
11
96
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
122
1.24
0.27
1.5
1.4
ug/g
213.3
293.4
—
9
73
(3020682) Albumin/Creatinine [Ratio] in Urine
133
1262
1.07
0.27
3.5
4.0
mg/mmol
3.9
9.3
2.49
90
801
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
419
4131
1.09
0.26
4.7
4.4
mmol/l
1.5
1.5
0.06
392
3802
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
405
3988
1.08
0.26
4.2
4.0
mmol/l
1.3
1.3
0.67
376
3656
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
71
0.70
0.26
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
72
0.69
0.26
2.0
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
75
1.20
0.25
2.0
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
96
1.26
0.24
1.8
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
78
1.29
0.24
1.2
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
106
1.23
0.23
1.4
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
92
0.76
0.22
1.0
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
461
0.90
0.22
1.5
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
47
512
0.91
0.22
2.3
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
120
1144
1.06
0.22
2.0
1.6
mmol/l
1.4
1.4
0.03
108
963
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
11
0.00
0.21
0.0
5.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
2.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.4
—
4096.7
—
0
7
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
4.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
49
1.23
0.20
1.7
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
57
610
0.93
0.19
1.3
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
34
309
1.11
0.19
4.8
4.6
%
0.4
0.3
—
9
79
(1002224) Polysomnography panel
16
185
0.86
0.18
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
34
310
1.10
0.18
1.5
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
68
1.18
0.16
1.3
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
70
1.15
0.16
2.6
2.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
79
0.76
0.15
2.0
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
46
430
1.08
0.15
4.2
4.2
ug/l
3.7
32.6
0.95
36
363
(3008898) HLA-B27 [Presence]
18
160
1.13
0.14
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
39
418
0.93
0.14
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
100
0.80
0.13
5.3
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
609
1.06
0.13
1.5
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
110
0.81
0.13
1.3
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
52
493
1.06
0.12
31.6
19.5
inr
1.4
1.2
—
8
71
(3041096) Erythrocytes [Presence] in Urine by Automated
110
1135
0.96
0.12
4.2
3.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
73
759
0.96
0.11
1.7
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
3.0
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
44
1.14
0.10
1.6
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
1.7
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
88
1.14
0.08
1.1
1.3
—
—
—
0
0
(3000492) Spirometry study
43
411
1.05
0.08
1.7
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
73
753
0.96
0.08
2.1
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
47
490
0.95
0.08
3.1
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.9
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
98
1.13
0.07
1.1
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
20
186
1.08
0.07
3.0
3.4
mmol/l
25.6
24.9
0.39
20
181
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
108
1.11
0.07
1.3
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
132
0.91
0.06
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
109
1.10
0.06
1.4
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
90
1.11
0.05
2.1
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
43
444
0.97
0.05
2.9
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
170
1.06
0.04
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
37
382
0.97
0.04
2.0
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
35
339
1.03
0.03
4.6
3.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
107
0.93
0.02
2.7
2.5
mmol/l
25.6
25.1
—
10
92
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
127
0.94
0.01
1.7
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
147
0.95
0.01
2.0
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
20
193
1.04
0.01
2.1
3.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
106
0.94
0.01
2.5
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
106
0.94
0.01
2.5
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
97
1.03
0.00
2.0
1.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
17
167
1.02
0.00
1.2
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
48
482
1.00
0.00
1.6
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
83.1
—
0
6
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
49
1.02
0.00
1.0
2.3
umol/l
3.7
4.0
—
5
34
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.5
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
69
1.01
0.00
1.3
3.1
e9/l
4.4
4.5
—
7
69
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
69
1.01
0.00
8.4
5.6
umol/l
416.7
380.5
—
7
61
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
56
0.89
0.00
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
86
0.93
0.00
1.1
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
10.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
62
0.97
0.00
1.5
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
69
0.87
0.00
1.2
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
72
0.97
0.00
1.6
3.5
%
57.1
56.9
—
7
72
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
89
1.01
0.00
1.3
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
72
0.97
0.00
1.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
2.0
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
69
0.87
0.00
1.2
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
69
0.87
0.00
3.0
2.9
u/ml
—
814.1
—
0
9
(3044941) Cell count panel - Synovial fluid
6
61
0.98
0.00
1.2
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
73
0.96
0.00
7.6
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_SPINAL_CORD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_SPINAL_CORD | 1.2 [0.99, 1.46] | 0.064 |
| Birth year | 0.996 [0.99, 1.0] | 0.315 |
During the follow-up period (1.1.1998 — 31.12.2019), 142 out of 1100 females with CD2_BENIGN_SPINAL_CORD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_SPINAL_CORD | 1.165 [0.93, 1.46] | 0.183 |
| Birth year | 0.99 [0.98, 1.0] | 0.045 |
During the follow-up period (1.1.1998 — 31.12.2019), 140 out of 1023 males with CD2_BENIGN_SPINAL_CORD died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_SPINAL_CORD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.107% | 0.251% |
| 5 | 0.634% | 1.359% |
| 10 | 1.786% | 3.458% |
| 15 | 3.536% | 6.946% |
| 20 | 6.393% | 11.864% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SPINAL_CORD – Benign neoplasm: Spinal cord
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data